|
(Sorry, Cheryl)...
I'm wholeheartedly supportive of what Becky spelled out... that we need to be very open to simpler, nonpharmacologic ways of improving our chances...
Yet... One reason I think the recurrence rates are worth discussing and dealing with is for those of us who are trying to decide whether to do more therapy or not.
In the case of those who so far have managed to stay NED and have been prevented by reasearchers from being included in the Herceptin trials, and who also were not ever treated with a taxane, I don't know of any information to help make the decision whether or not to do Herceptin or even newer treatments. Does anyone know of any helpful statistics?
Thanks,
AlaskaAngel
T1c ER+ PR+ HER2+++
|